The Discovery and Efficacy of a Small Molecule Inhibitor of Ebola Capsid Assembly in an Animal Model
Jean Francis, Vishwanath R. Lingappa(University of California, San Francisco), Travis K. Warren(London School of Hygiene & Tropical Medicine), Sina Bavari(Epix Pharmaceuticals (United States)), Clarence R. Hurt, Warren V. Kalina(Pfizer (United States)), Abhar Nissar, Anatoliy Kitaygorodskyy, Katie J. Edwards(Calspan-University of Buffalo Research Center), I.-ting Jaing, William Hansen, A. Pia Abola
Cited by 1
Related Papers
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
|New England Journal of Medicine|2020|15.7k
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
|New England Journal of Medicine|2020|2.7k
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults
|Nature|2020|1.6k
Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents
|New England Journal of Medicine|2021|937